Timolol maleate a gold standard drug in glaucoma used as ocular films and inserts: An overview

International Journal of Pharmaceutical Sciences Review and Research

Volumn 3, Issue 1, 2010, Pages 23-29

  Rathore, Kamal Singh ^a   Nema, Rajesh Kumar ^b   Sisodia, Sidhraj Singh ^c  

^a BN College of Pharmacy   (India)

^b Rishiraj Institute of Technology   (India)

^c BN College of Pharmacy   (India)

Author keywords

Erodible systems; Ocular films; Ocular inserts; Osmotic systems; Timolol maleate

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CELLULOSE ACETATE; CHLORPROMAZINE; CLONIDINE; CYTOCHROME P450 2D6; DIGOXIN; DILTIAZEM; EUDRAGIT RS; EYE DROPS; GLUCAGON; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; INSULIN; LIPOSOME; MACROGOL; NANOPARTICLE; NIOSOME; PHTHALIC ACID DIETHYL ESTER; POLYVINYL ALCOHOL; PRAZOSIN; PYRAN COPOLYMER; SALBUTAMOL; SALICYLIC ACID DERIVATIVE; SULFONYLUREA DERIVATIVE; TERAZOSIN; TIMOLOL MALEATE; UNINDEXED DRUG; VERAPAMIL;

BLURRED VISION; BRADYCARDIA; CATARACT; CONTROLLED RELEASE FORMULATION; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG INHIBITION; DRUG INTOXICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PACKAGING; DRUG POTENTIATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DYSPNEA; EMULSION; EYE BURNING; FATIGUE; GLAUCOMA; GOLD STANDARD; HEADACHE; HEART INFARCTION; HUMAN; HYDROPHILICITY; HYPERTENSION; INFECTION; INTRAOCULAR PRESSURE; MAXIMUM PLASMA CONCENTRATION; MELTING POINT; MIGRAINE; MOLECULAR WEIGHT; NAUSEA AND VOMITING; NONHUMAN; OCULAR PRURITUS; RECEPTOR BLOCKING; REVIEW; SIDE EFFECT; SUSPENSION; SUSTAINED RELEASE FORMULATION; VISUAL ACUITY;

EID: 79952027645     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Bagool M.A., "Topical ocular drug delivery: A Review", 1993; Indian Drugs, 31 (10): pp 451-56.
2. Kamal S Rathore, R. K. Nema, (Jan42009), "Glaucoma: a review" published on-line at www.earticlesonline.com.
3. Maichuk Y.F. and Ericher V.P. "Glaucoma" 1981, 3: p 329.
4. Rastogi S., Mishra B. "Ophthalmic inserts - An overview" 1996; The Eastern Pharmacist, Feb: pp 41-44.
5. Rathore KS, Nema RK. (Apr.-June.2009), "An Insight into Ophthalmic Drug Delivery System", published online at www.ijpsdr.com. Issue.
6. Rathore KS, Nema RK. (April-June 2009), "Review on Ocular inserts" International Journal of Pharm tech Research, Vol.1, No.2, pp 164-169
7. Rathore KS, Nema RK. (April-June 2009), "Review on Ocular inserts" International Journal of Pharm tech Research, Vol.1, No.2, pp 164-169
8. Rathore KS, Nema RK. (July-Sept 2009), "Management of Glaucoma: a Review" International Journal of Pharm Tech Research, Vol.1, No.3, pp, 863-869.
9. Rathore KS, Nema RK. (October-December, 2008), "Formulation and evaluation of ophthalmic films for timolol maleate" planta indica, vol.no.4, p49-50.
10. Wagenvoort AM, van Vugt JM, Sobotka M, et al, "Topical Timolol Therapy in Pregnancy: Is It Safe for the Fetus?" Teratology, 1998, 58(6):258-62.
11. Rosenlund E. The intraocular pressure lowering effect of timolol in gel forming solution. Acta Ophthalmol Scand 1996; 74:160 -162.
12. Van Buskirk EM, Fraunfelder FT. Ocular beta- blockers and systemic effects. Am J Ophrhalmol. 1984; 98:623-624.
13. Gibbons RJ, Abrams J, Chatterjee K, et al, J Am Coll Cardiol, 2003, 41(1):159-68.
14. Wolfhagen, F.S.H., Groen, F.C., Ouwendijk, R.J., 1998. Severe nausea and vomiting with timolol eye drops. Lancet 352, 373.
15. Zimmerman TJ, Kaufman HE. Timolol, dose response and duration of action. Arch Ophthalmol 1977; 95:605- 607.
16. Mundorf TK, Ogawa T, Naka H, et al, Clin Ther, 2004, 26(4):541-51.
17. K.S.Rathore, R.K.Nema, S.S.Sisodia, Formulation and Evaluation of Brimonidine Tartrate Ocular Films. The Pharma Review (Mar 2010), p.133-138.
18. Jain, S.P., Shah, S., Singh P.P. (2007). Twice a day ocular inserts of acyclovir by melt extrusion technique. Indian journal of Pharmaceutical Sciences, July-Sept., p 562-66.
19. Abhilash, A.S., Jayaprakash, S., Nagarajan, M., Dhachinamoorthi, D. Design and Evaluation of Timolol Maleate Ocuserts. Ind J Pharm Sci 2005; 67(3):311-4.
20. Horwath-Winter, J., Schmut, O., Haller-Schober, E.M., Gruber, A., Rieger, G., Br.J.Ophthalmol.2005, 89(1), 40.
21. Eljarrat-Binstock, E., Raiskup, F., Frucht-Pery, J., Domb, A.J. J.Biomater.Sci.Polym.I'd. 2004, 15(4), 397.
22. Hayden, B.C., Jockovich, M.E., Murray, T.G. et al., Invest. Ophthalmol. Vis. Sci. 2004, 45(10), 3644.
23. Dandagi, P.M., Manvi, F.V., Patil, M.B., Mastiholimath, V.S., Rathod, R. Development and Evaluation of Ocular films of Cromolyn Sodium. Ind J Pharm Sci 2004 May-June; 66(3):309-12.
24. Rao V., Shyale, S. Preparation and Evaluation of Ocular Inserts containing Norfloxacin. Turk J Med Sci 2004; 34:230-46.
25. Charoo, N.A., Kohli, K., Ali, A., Anwer, A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug Dev Ind Pharm 2003 Feb; 29(2):215-21.
26. Pandit, J.K., Harikumar, S.L., Mishra, D.N., Balasubramaniam, J. Effect of Physical Cross-linking on in vitro and ex vivo permeation of indomethacin from polyvinyl alcohol ocular inserts. Ind J Pharm Sci 2003; 65(2):146-151.
27. Vaithiyalingam, S., Nutan, M., Reddy, I., Khan, M. Preparation and Characterization of a customized cellulose acetate butyrate dispersion for controlled drug delivery. J Pharm Sci 2002 Jun; 91(6):1512-22.
28. Di Colo, G, Zambito, Y. Studies of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly (ethylene oxide). Eur J Pharm Biopharm 2002; 54(2):193-9.
29. Verma, P.R.P., Sharan, N., Jha, L.L. Release profile of flurbiprofen from ointment bases through cellulose acetate film. The Eastern Pharmacist 2001 Dec; XLIV (528):108-9.
30. Vijaya, C., Somnath, S., Gerald Rajan, N.S.M., Jayaprakash, S., Nagarajan, M. Controlled release ocuserts of Chloramphenicol-design and evaluation. The Eastern Pharmacist 2001 Apr; XLIV (520):105-8.
31. Jayaprakash, S., James, C.C., Gerald Rajan, N.S.M., Saisivam, S., Nagarajan, M. Design and Evaluation of Ketorolac Tromethamine Ocuserts. Ind J Pharm Sci 2000; 62(5):334-8.
32. Y.C.Lee, Millard, J.W., Negvesky, G.J., Butrus, S.I., Yalkowsky, S.H. (1999). Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. International Journal of Pharmaceutics, 182, 121-126.
33. Bharath, S, Hiremath, S.R. Ocular delivery systems of pefloxacin mesylate. Pharmazie 1999 Jan; 54(1):55-8.
34. Saisivam, S., Manikandar, R.V.M., Nagarajan, M. Design and Evaluation of Ciprofloxacin Hydrochloride Ocuserts. Ind J Pharm Sci 1999; 61(1):34-8.
35. Manikandar, R.V.M., Narkilli, R.S.N., Prabhakaran, P., Ranjithkumar, R., Karthikayini, M., Ramanathan, A. Polymeric ocular drug delivery of diclofenac sodium ophthalmic inserts. The Eastern Pharmacist 1998 Jul; 131-2.
36. Donnenfeld, E.D., et al. "Intracorneal, aqueous humor and vitreous humor penetration of topical and oral Ofloxacin". Arch. Ophthalmol, 1997; 1592: 173.
37. Akkan, A.G., et al, "Penetration of topically applied ciprofloxacin norfloxacin and Ofloxacin into the aqueous humor of the uninflamed human eye". J. Chemotherapy. 1997; 9(4): 257.
38. Soppimath, K.S, Manvi, F.V., Gadad, A.P. Development and Evaluation of Timolol Maleate ocular inserts. Indian Drugs 1997 May; 34(5):264-8.
39. Narsimha Murthy, S., et al., "Biodegradable polymer matrix based Ocuserts of Diclofenac sodium". Indian Drugs, 1997; 34(6): 336-8.
40. Cohen, R.G., et al. "Retinal safety of oral and topical Ofloxacin in rabbits". Journal of Ocular Pharmacology and therapeutics, 1997; 13(4): 369.
41. Brodovsky, S.C., Snibson, G.R., "Corneal and conjunctival infections". Current opinion in Ophthalmology, 1997; 16(2): 209.
42. Urtti, A., et al. "Controlled drug delivery devices for experimental ocular studies with timolol. 1. In-vitro release studies. 2. Ocular and systemic absorption in rabbits". Int. J. Pharm., 1990; 61: 235.
43. Lee VHL. Influence of drug release rate on systemic timolol absorption from polymeric ocular inserts in the pigmented rabbit. J Ocul Pharmcol 1994; 10(2); 421-7.
44. Sasaki, H., Tei, C., Nishida, K., Nakamura, J. Drug release from an ophthalmic insert of a beta-blocker as an ocular drug delivery system. J Control Release 1993; 27:127-37.
45. Shanawany, E.L., "Ocular delivery of pilocarpine from ocular inserts". STP. Pharma Sciences, 1992; 2(4): 337.
46. Saettone, M.F., Torraca, A., Pagano, B., Giannaccini, B., Rodriquez, L., Cini, M. Controlled release of pilocarpine from coated polymeric ophthalmic inserts prepared by extrusion. Int J Pharm 1992 Oct; 86:159-66.
47. Chowdary, K.P.R., Naidu, R.A.S. Preparation and evaluation of cellulose acetate films as rate controlling membranes for transdermal use. Indian Drugs 1991; 29(7):312-315.
48. Attia, A., Kassem, M.A., Safwat, S.M. In vivo performance of [3H]dexamethasone ophthalmic film delivery systems in the rabbit eye. Int J Pharm 1988 Nov; 47:21-30.
49. Grass, G.M, et al. "Ocular Delivery of pilocarpine from erodible matrices". J. Pharm. Sci; 1984; 73(5): 618-20.
50. Gruneberg, R.N., et al. "The comparative in vitro activity of Ofloxacin". J. Antimicrobo. Chemotherapy. 1988; 22(9): 9.
51. Bloomfield, S.E., Miyata, T., Dunn, M.W., Soluble gentamicin ophthalmic inserts as a drug delivery system. Arch Ophthalmol 1978; 96:885.
52. Maichuk, Yu.F., Davydov, A.B., Khromov, T.A., et al., Farmatsiya, 1978, no. 1.